1096 related articles for article (PubMed ID: 19451853)
1. Drug use density in critically ill children and newborns: analysis of various methodologies.
Valcourt K; Norozian F; Lee H; Raszynski A; Torbati D; Totapally BR
Pediatr Crit Care Med; 2009 Jul; 10(4):495-9. PubMed ID: 19451853
[TBL] [Abstract][Full Text] [Related]
2. Preliminary experience with the use of oral linezolid in infants for the completion of antibiotic therapy in the outpatient setting after admission to the pediatric intensive care unit.
Sullivan J; Tobias JD
Am J Ther; 2006; 13(6):473-7. PubMed ID: 17122526
[TBL] [Abstract][Full Text] [Related]
3. Impact of linezolid on economic outcomes and determinants of cost in a clinical trial evaluating patients with MRSA complicated skin and soft-tissue infections.
McKinnon PS; Sorensen SV; Liu LZ; Itani KM
Ann Pharmacother; 2006 Jun; 40(6):1017-23. PubMed ID: 16720705
[TBL] [Abstract][Full Text] [Related]
4. Hematologic effects of linezolid in young children.
Meissner HC; Townsend T; Wenman W; Kaplan SL; Morfin MR; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S186-92. PubMed ID: 14520145
[TBL] [Abstract][Full Text] [Related]
5. Acute kidney injury during vancomycin therapy in critically ill children.
Totapally BR; Machado J; Lee H; Paredes A; Raszynski A
Pharmacotherapy; 2013 Jun; 33(6):598-602. PubMed ID: 23526674
[TBL] [Abstract][Full Text] [Related]
6. Vancomycin pharmacokinetic-pharmacodynamic parameters to optimize dosage administration in critically ill children.
Giachetto GA; Telechea HM; Speranza N; Oyarzun M; Nanni L; Menchaca A
Pediatr Crit Care Med; 2011 Nov; 12(6):e250-4. PubMed ID: 21057350
[TBL] [Abstract][Full Text] [Related]
7. Trends in antibiotic use at a university hospital: defined or prescribed daily doses? Patient days or admissions as denominator?
de With K; Maier L; Steib-Bauert M; Kern P; Kern WV
Infection; 2006 Apr; 34(2):91-4. PubMed ID: 16703299
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of treatments used in infections caused by gram-positive multiresistant cocci in critically ill patients admitted to the ICU].
Álvarez-Lerma F; Palomar Martínez M; Olaechea Astigarraga P; Insausti Ordeñana J; López Pueyo MJ; Gracia Arnillas MP; Gimeno Costa R; Seijas Betolaza I
Rev Esp Quimioter; 2012 Mar; 25(1):65-73. PubMed ID: 22488544
[TBL] [Abstract][Full Text] [Related]
9. Is linezolid a risk factor for Gram-negative bacillus infections in intensive care unit patients? A comparative study with vancomycin.
Sterzik H; Soriano A; Mohamad AM; Martínez JA; Fernandez J; Cobos N; Morata L; Mensa J
Scand J Infect Dis; 2011 Oct; 43(10):765-70. PubMed ID: 21696252
[TBL] [Abstract][Full Text] [Related]
10. The economic effect of oral linezolid versus intravenous vancomycin in the outpatient setting: the payer perspective.
McKinnon PS; Carter CT; Girase PG; Liu LZ; Carmeli Y
Manag Care Interface; 2007 Jan; 20(1):23-34. PubMed ID: 17310650
[TBL] [Abstract][Full Text] [Related]
11. Vancomycin dosage requirements among pediatric intensive care unit patients with normal renal function.
Glover ML; Cole E; Wolfsdorf J
J Crit Care; 2000 Mar; 15(1):1-4. PubMed ID: 10757191
[TBL] [Abstract][Full Text] [Related]
12. Energy expenditure and balance following pediatric intensive care unit admission: a longitudinal study of critically ill children.
Oosterveld MJ; Van Der Kuip M; De Meer K; De Greef HJ; Gemke RJ
Pediatr Crit Care Med; 2006 Mar; 7(2):147-53. PubMed ID: 16531947
[TBL] [Abstract][Full Text] [Related]
13. Early switch from vancomycin to oral linezolid for treatment of gram-positive heart valve endocarditis.
Colli A; Campodonico R; Gherli T
Ann Thorac Surg; 2007 Jul; 84(1):87-91. PubMed ID: 17588391
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic use in non-university regional acute care general hospitals in southwestern Germany, 2001-2002.
Kern WV; de With K; Steib-Bauert M; Fellhauer M; Plangger A; Probst W;
Infection; 2005 Oct; 33(5-6):333-9. PubMed ID: 16258863
[TBL] [Abstract][Full Text] [Related]
15. Extubation failure in pediatric intensive care incidence and outcomes.
Baisch SD; Wheeler WB; Kurachek SC; Cornfield DN
Pediatr Crit Care Med; 2005 May; 6(3):312-8. PubMed ID: 15857531
[TBL] [Abstract][Full Text] [Related]
16. Inpatient treatment patterns, outcomes, and costs of skin and skin structure infections because of Staphylococcus aureus.
Menzin J; Marton JP; Meyers JL; Carson RT; Rothermel CD; Friedman M
Am J Infect Control; 2010 Feb; 38(1):44-9. PubMed ID: 19762120
[TBL] [Abstract][Full Text] [Related]
17. The impact of linezolid and vancomycin treatment on local signs and symptoms of inflammation among pediatric patients with complicated skin and skin structure infections.
Deville JG; Equils O; Huang DB; Ang JY
Clin Pediatr (Phila); 2011 Nov; 50(11):1064-7. PubMed ID: 21098522
[No Abstract] [Full Text] [Related]
18. Linezolid for the treatment of infections caused by Gram-positive pathogens in China.
Lin DF; Zhang YY; Wu JF; Wang F; Zheng JC; Miao JZ; Zheng LY; Sheng RY; Zhou X; Shen HH; Ijzerman MM; Croos-Dabrera RV; Sheng W
Int J Antimicrob Agents; 2008 Sep; 32(3):241-9. PubMed ID: 18635341
[TBL] [Abstract][Full Text] [Related]
19. Survival of critically ill patients hospitalized in and out of intensive care.
Simchen E; Sprung CL; Galai N; Zitser-Gurevich Y; Bar-Lavi Y; Levi L; Zveibil F; Mandel M; Mnatzaganian G; Goldschmidt N; Ekka-Zohar A; Weiss-Salz I
Crit Care Med; 2007 Feb; 35(2):449-57. PubMed ID: 17167350
[TBL] [Abstract][Full Text] [Related]
20. Comparison of critically ill and injured children transferred from referring hospitals versus in-house admissions.
Gregory CJ; Nasrollahzadeh F; Dharmar M; Parsapour K; Marcin JP
Pediatrics; 2008 Apr; 121(4):e906-11. PubMed ID: 18381519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
